The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Open accessAbstract
Infectious diseases are a significant burden on public health and economic stability of societies all over the world. They have for centuries been among the leading causes of death and disability and presented growing challenges to health security and human progress. The threat posed by infectious diseases is further deepened by the continued emergence of new, unrecognized, and old infectious disease epidemics of global impact. Over the past three and half decades at least 30 new infectious agents affecting humans have emerged, most of which are zoonotic and their origins have been shown to correlate significantly with socioeconomic, environmental, and ecological factors. As these factors continue to increase, putting people in increased contact with the disease causing pathogens, there is concern that infectious diseases may continue to present a formidable challenge. Constant awareness and pursuance of effective strategies for controlling infectious diseases and disease emergence thus remain crucial. This review presents current updates on emerging and neglected infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with particular focus on WHO top priority emerging infectious diseases (EIDs) and neglected tropical infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hotez, P. J., Alvarado, M., Basáñez, M.-G., Bolliger, I., Bourne, R., Boussinesq, M., Brooker, S. J., Brown, A. S., Buckle, G., Budke, C. M., et al. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002865 · Cited by 1,082
Prediction and prevention of the next pandemic zoonosis.
Morse, S. S., Mazet, J. A., Woolhouse, M., Parrish, C. R., Carroll, D., Karesh, W. B., Zambrana-Torrelio, C., Lipkin, W. I., & Daszak, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61684-5 · Cited by 1,070 · cited 1×
“These pathogens are mostly transmitted though intermediate animal hosts such as rodents [1, 54] , which gain increased contact with humans as a result of environmental and human behavioural factors (Table 1) .”
BackgroundDisease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908 · cited 1×
“By understanding the dynamics of disease and the means of contracting it, methods of fighting, preventing, and controlling are developed [2, 5, 6].”
Feasey, N., Wansbrough-Jones, M., Mabey, D. C. W., & Solomon, A. W. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp046 · Cited by 817
Drivers, dynamics, and control of emerging vector-borne zoonotic diseases
Kilpatrick, A. M., & Randolph, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61151-9 · Cited by 812
Emerging Infections: Microbial Threats to Health in the United States
Lederberg, J., Shope, R. E., & Oaks, S. C. (1992) · Defense Technical Information Center (DTIC) · Cited by 772
How urbanization affects the epidemiology of emerging infectious diseases
Neiderud, C.-J. (2015) · Infection Ecology & Epidemiology · doi:10.3402/iee.v5.27060 · Cited by 633
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627 · cited 1×
“Combination ART is necessary to suppress plasma HIV viremia, restore immunologic function, and reduce likelihood of drug resistance development for favourable treatment outcomes [109] .”
BackgroundSickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
Ashley-Koch, A., Yang, Q., & Olney, R. S. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010288 · Cited by 528 · cited 1×
“Over the past three and half decades at least 30 new infectious agents affecting humans have emerged, most of which are zoonotic and their origins have been shown to correlate significantly with socioeconomic, environmental, and ecological factors.”
BackgroundThe Perpetual Challenge of Infectious Diseases
Fauci, A. S., & Morens, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108296 · Cited by 517
Global Patterns of Zoonotic Disease in Mammals
Han, B. A., Kramer, A. M., & Drake, J. M. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.04.007 · Cited by 508
MERS coronavirus: diagnostics, epidemiology and transmission
Mackay, I. M., & Arden, K. E. (2015) · Virology Journal · doi:10.1186/s12985-015-0439-5 · Cited by 388
After 2015: infectious diseases in a new era of health and development
Dye, C. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0426 · Cited by 361
Global burden, distribution, and interventions for infectious diseases of poverty
Bhutta, Z. A., Sommerfeld, J., Lassi, Z. S., Salam, R. A., & Das, J. K. (2014) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-3-21 · Cited by 342
Emerging infections: a perpetual challenge
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70256-1 · Cited by 313
Stigma and the Social Burden of Neglected Tropical Diseases
Weiss, M. G. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000237 · Cited by 286
Globalization and infectious diseases, A review of the linkages
Saker, L., Lee, K., Cannito, B., Gilmore, A., & Campbell-Lendrum, D. H. (2004) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 276
An Introduction to Ebola: The Virus and the Disease
Peters, C. J., & LeDuc, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514322 · Cited by 260
Conflict and Emerging Infectious Diseases
Gayer, M., Legros, D., Formenty, P., & Connolly, M. A. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1311.061093 · Cited by 251
HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
Calmy, A., Ford, N., Hirschel, B., Reynolds, S. J., Lynen, L., Goemaere, E., de la Vega, F. G., Perrin, L., & Rodriguez, W. (2007) · Clinical Infectious Diseases · doi:10.1086/510073 · Cited by 247
Fauci, A. S., Touchette, N. A., & Folkers, G. K. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1104.041167 · Cited by 243
Deribe, K., Meribo, K., Gebre, T., Hailu, A., Ali, A., Aseffa, A., & Davey, G. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-240 · Cited by 226
Epidemics and Pandemics: Their Impacts on Human History
Hays, J. N. (2005) · Cited by 201
Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread
Klein, E. Y. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.007 · Cited by 198
The Global Fight Against HIV/AIDS, Tuberculosis, and Malaria
Vitoria, M., Granich, R., Gilks, C. F., Gunneberg, C., Hosseini, M., Were, W., Raviglione, M., & De Cock, K. M. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp5xhdb1pnaeyt · Cited by 187
Human genetics of infectious diseases: between proof of principle and paradigm
Alcaïs, A., Abel, L., & Casanova, J.-L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38111 · Cited by 182
Defo, B. K. (2014) · Global Health Action · doi:10.3402/gha.v7.22443 · Cited by 177
Mayer, K. H., & Beyrer, C. (2007) · Clinical Infectious Diseases · doi:10.1086/512371 · Cited by 169
Perspectives on West Africa Ebola Virus Disease Outbreak, 2013–2016
Spengler, J. R., Ervin, E. D., Towner, J. S., Rollin, P. E., & Nichol, S. T. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2206.160021 · Cited by 159
Bockarie, M. J., Kelly‐Hope, L. A., Rebollo, M. P., & Molyneux, D. H. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0144 · Cited by 145
Determinants and Drivers of Infectious Disease Threat Events in Europe
Semenza, J. C., Lindgren, E., Balkányi, L., Espinosa, L., Almqvist, M. S., Penttinen, P. M., & Rocklöv, J. (2016) · Emerging infectious diseases · doi:10.3201/eid2204.151073 · Cited by 138
Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic
Shanks, G. D., & Brundage, J. F. (2012) · Emerging infectious diseases · doi:10.3201/eid1802.102042 · Cited by 117
Molecular diagnostics of infectious diseases
Muldrew, K. L. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328320d87e · Cited by 105
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report
Morens, D. M., & Fauci, A. S. (2012) · mBio · doi:10.1128/mbio.00494-12 · Cited by 97
Evolution of Measles Elimination Strategies in the United States
Orenstein, W. A., Hinman, A. R., & Papania, M. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/377694 · Cited by 90
Control of neglected tropical diseases needs a long-term commitment
Zhang, Y., MacArthur, C., Mubila, L., & Baker, S. K. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-67 · Cited by 86
Urbanization and tropical health — then and now
Utzinger, J., & Keiser, J. (2006) · Annals of Tropical Medicine and Parasitology · doi:10.1179/136485906x97372 · Cited by 75
Surveillance and Response to Disease Emergence
Merianos, A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_19 · Cited by 64
Kappagoda, S., & Ioannidis, J. P. A. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.129601 · Cited by 63
Encyclopedia of infectious diseases: modern methodologies
Goodman, R. A., Tibayrenc, M., & Someone, M. T. I. (2008) · Choice Reviews Online · doi:10.5860/choice.45-3534 · Cited by 62
Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
Yost, R. J., Pasquale, T. R., & Sahloff, E. G. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080206 · Cited by 54
Racaniello, V. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21370 · Cited by 46
[Impact of changes in the environment on vector-transmitted diseases].
Mouchet, J., & Carnevale, P. (1997) · PubMed · Cited by 40
Emerging infectious diseases: vulnerabilities, contributing factors and approaches
Lashley, F. R. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.299 · Cited by 38
The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov
Goswami, N. D., Pfeiffer, C. D., Horton, J. R., Chiswell, K., Tasneem, A., & Tsalik, E. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077086 · Cited by 37
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
Goba, A., Khan, S. H., Fonnie, M., Fullah, M., Moigboi, A., Kovoma, A., Sinnah, V., Yoko, N., Rogers, H., Safai, S., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw239 · Cited by 36
Social and Economic Impact Review on Neglected Tropical Diseases
Adelman, C. C., Marano, K., Norris, J. A., & Spantchak, Y. (2012) · Cited by 30
Baker, J. P. (2011) · PEDIATRICS · doi:10.1542/peds.2011-1430 · Cited by 29
Perspectives of public health laboratories in emerging infectious diseases
Chua, K. B., & Gubler, D. J. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.34 · Cited by 25
Microbial Pathogenesis: Mechanisms of Infectious Disease
Carruthers, V. B., Cotter, P. A., & Kumamoto, C. A. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.007 · Cited by 19
Marty, C. A. M., Conran, C. R. M., & Kortepeter, L. M. G. (2001) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30016-7 · Cited by 11
Lima, V. D., Granich, R., Phillips, P., Williams, B. G., & Montaner, J. S. G. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit406 · Cited by 10
Cited by
Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review
Chala, B., & Hamde, F. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.715759 · Cited by 390
Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus
Łoczechin, A., Séron, K., Barras, A., Giovanelli, E., Belouzard, S., Chen, Y.-T., Metzler-Nolte, N., Boukherroub, R., Dubuisson, J., & Szunerits, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15032 · Cited by 320
Immunoinformatics and Vaccine Development: An Overview
Oli, A. N., Obialor, W. O., Ifeanyichukwu, M. O., Odimegwu, D. C., Okoyeh, J. N., Emechebe, G. O., Adejumo, S. A., & Ibeanu, G. C. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s241064 · Cited by 281
Nguyen, D. D., & Lai, J.-Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134970 · Cited by 178
Metadata
- Authors
- Nii-Trebi, N. I.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2589048181
- Cited by
- 356
- References
- 53
- FWCI
- 22.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.